Hikma Pharmaceuticals (OTCMKTS:HKMPF) Trading Down 1.2% - What's Next?

Key Points

• Hikma Pharmaceuticals shares experienced a decline of 1.2%, trading at $22.16 on Monday, with a total trading volume of 2,540 shares, a significant increase from the average of 1,198 shares.
• The company's 50-day simple moving average is $25.59, while the 200-day simple moving average is $26.47, indicating a downward trend in stock valuation.
• Hikma operates through three main segments: Injectables, Generics, and Branded pharmaceuticals, focusing primarily on generic injectable products for hospital use.

Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF - ) shares fell 1.2% during mid-day trading on Monday . The stock traded as low as $22.16 and last traded at $22.16. 2,540 shares were traded during trading, an increase of 112% from the average session volume of 1,198 shares. The stock had previously closed at $22.42.

Hikma Pharmaceuticals Stock Down 1.2%

The firm's 50 day simple moving average is $25.59 and its 200-day simple moving average is $26.47. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.72 and a current ratio of 1.24.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.